120 related articles for article (PubMed ID: 37905967)
1. The Iron Status of Children with and without Sickle Cell Disease at the University of Ilorin Teaching Hospital, Nigeria.
Akintola MA; Ibraheem RM; Biliaminu SA; Ernest SK; Ojuawo A
West Afr J Med; 2023 Oct; 40(10):1013-1020. PubMed ID: 37905967
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Function in Egyptian Children with Sickle Cell Anemia in Correlation with Iron Load.
Hagag AA; El-Asy HM; Badraia IM; Hablas NM; El-Latif AEA
Endocr Metab Immune Disord Drug Targets; 2019; 19(1):46-52. PubMed ID: 30207251
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and hepcidin expression in pediatric sickle cell anemia with iron overload.
Elbostany EA; Elghoroury EA; Thabet EH; Rashad AA; Rasheed EA; El-Saeed GSM; Abdelhalim DA; Abdelfattah SN; Salama II; Salama N
Hematol Oncol Stem Cell Ther; 2023 Apr; 16(3):238-244. PubMed ID: 34883086
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial impact of sickle cell disease in children seen at University of Ilorin Teaching Hospital, Ilorin, Nigeria.
Tunde-Ayinmode MF; Adelekan ML
East Afr Med J; 2005 Feb; 82(2):73-8. PubMed ID: 16122095
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial impact of sickle cell disease on mothers of affected children seen at University of Ilorin Teaching Hospital, Ilorin, Nigeria.
Tunde-Ayinmode MF
East Afr Med J; 2007 Sep; 84(9):410-9. PubMed ID: 18074959
[TBL] [Abstract][Full Text] [Related]
6. Utility of plasma transferrin receptor, ferritin and inflammatory markers in children with sickle cell disease.
Al-Saqladi AW; Bin-Gadeem HA; Brabin BJ
Paediatr Int Child Health; 2012 Feb; 32(1):27-34. PubMed ID: 22525445
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Functional iron status of chronic kidney disease patients at the University of Ilorin Teaching Hospital, Ilorin, Nigeria.
Sanni EO; Olawumi HO; Durotoye IA; Olanrewaju TO; Babatunde AS; Shittu OA; Biliaminu SA; Omokanye KO; Ogunfemi MK; Akinwumi OO; Oyedepo DS; Adepoju AM
Afr Health Sci; 2022 Sep; 22(3):718-725. PubMed ID: 36910371
[TBL] [Abstract][Full Text] [Related]
9. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
[TBL] [Abstract][Full Text] [Related]
10. Serum iron Profile of Patients with Sickle Cell Disease and its Association with Socio-demographic Characteristics and Duration of Diagnosis.
Kamar SB; Pandey H; Puri S; Shahi R; Bhatta U; Khadka S; Yadav GK; Subedi P; Amgain K
J Nepal Health Res Counc; 2024 Mar; 21(4):550-556. PubMed ID: 38616582
[TBL] [Abstract][Full Text] [Related]
11. Burden of iron overload among non-chronically blood transfused preschool children with sickle cell anaemia.
Olufemi AS; Folashade AA; Adetutu OT
Afr Health Sci; 2021 Jun; 21(2):753-758. PubMed ID: 34795732
[TBL] [Abstract][Full Text] [Related]
12. Iron deficiency, still a rarity in children with sickle cell anemia in Ile-Ife, Nigeria.
Odunlade O; Adeodu O; Owa J; Obuotor E
Hematol Transfus Cell Ther; 2019; 41(3):216-221. PubMed ID: 31085147
[TBL] [Abstract][Full Text] [Related]
13. comparative study of carbohydrate antigen 19-9 in sickle cell disease subjects and controls in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Manafa P; Okocha C; Nwogho B; Aneke J; Okpara PSD; Lbeh N; Chukwuma G; Manafa V; Nwane E
Afr Health Sci; 2018 Dec; 18(4):1003-1009. PubMed ID: 30766566
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of manual chronic partial exchange transfusion in children with sickle disease.
Aloni MN; Lê PQ; Heijmans C; Huybrechts S; Devalck C; Azzi N; Ngalula-Mujinga M; Ferster A
Hematology; 2015 Jun; 20(5):284-8. PubMed ID: 25133935
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial of riboflavin in sickle cell disease.
Ajayi OA; George BO; Ipadeola T
East Afr Med J; 1993 Jul; 70(7):418-21. PubMed ID: 8293700
[TBL] [Abstract][Full Text] [Related]
16. Study of gonadal hormones in Egyptian female children with sickle cell anemia in correlation with iron overload: Single center study.
Hagag AA; El-Farargy MS; Elrefaey S; Abo El-enein AM
Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):1-7. PubMed ID: 26684919
[TBL] [Abstract][Full Text] [Related]
17. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
[TBL] [Abstract][Full Text] [Related]
18. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
19. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.
Ballas SK
Semin Hematol; 2001 Jan; 38(1 Suppl 1):30-6. PubMed ID: 11206959
[TBL] [Abstract][Full Text] [Related]
20. Serum iron status of under-five children with sickle cell anaemia in lagos, Nigeria.
Akodu SO; Diaku-Akinwumi IN; Kehinde OA; Njokanma OF
Anemia; 2013; 2013():254765. PubMed ID: 24288599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
